Samyak International Ltd will raise ₹13.6 crore by issuing equity shares and convertible warrants. The preferential issue requires member and regulatory approvals, with an EGM scheduled for July 9, 2026.

Samyak International Plans ₹13.6 Crore Capital Raise

Samyak International Ltd will raise ₹13.6 crore through a preferential issue of equity shares and convertible warrants.

Reader Takeaway: Capital infusion aims to bolster finances; dilution and approvals are key concerns.

What just happened

Samyak International Ltd's board has approved a preferential issue of securities. This includes the issuance of 40,00,000 equity shares and 40,00,000 convertible warrants at an issue price of ₹17 per unit (₹10 face value + ₹7 premium).

The total intended capital infusion amounts to ₹13.6 crore, comprising ₹6.8 crore from equity shares and ₹6.8 crore from warrants.

Why this matters

This preferential issue represents a significant capital-raising initiative for Samyak International. The capital infusion is intended to strengthen the company's financial position. However, it will also lead to the dilution of existing shareholding.

The issuance is open to both promoter and non-promoter entities, potentially altering the company's shareholder structure.

The backstory

This is a capital raising event aimed at enhancing the company's financial resources. The specific need for this capital is not detailed in the filing.

What changes now

The company has convened an Extra-Ordinary General Meeting (EGM) on July 9, 2026, to seek shareholder approval for this preferential issuance. A Preferential Allotment Committee has also been formed to oversee the process.

Risks to watch

The preferential issue is contingent upon several approvals: member approval at the EGM, in-principle approval from the stock exchange, and other necessary regulatory and statutory clearances.

Peer comparison

Information on peer capital-raising activities is not available in the filing.

Context metrics (time-bound)

• EGM Date: July 9, 2026
• Total Capital Infusion: ₹13.6 crore
• Equity Shares Offered: 40,00,000
• Convertible Warrants Offered: 40,00,000
• Issue Price: ₹17 per unit

What to track next

Investors should monitor the outcome of the EGM on July 9, 2026, and subsequent regulatory announcements regarding the approval and completion of this preferential issue.